Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region – 2020 to 2025

$3,850.00$5,850.00

Published on: March 24, 2020
Clear
SKU: GMS-2117 Category:

OVERVIEW

The global market for gene therapy is forecast at USD 14.65 billion by 2025, growing at a CAGR of 27.12%. This market’s growth is driven primarily by the high incidence of cancer and other target diseases, the availability of reimbursements, and the growing funding for gene therapy research.

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 1

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 2

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 3

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 4

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 5

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 6

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 7

Gene Therapy Market by Delivery Method (In-Vivo, Ex-Vivo), Vectors ( Viral, Non-viral, Adeno-associated), Indication (Neurological Diseases, Cancer), Region - 2020 to 2025 8

TABLE OF CONTENT

1 Global Gene Therapy Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Gene Therapy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Gene Therapy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Gene Therapy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Gene Therapy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Gene Therapy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Gene Therapy Market – By Vector (Market Size – & million/billion)
8.1 Non-Viral Vectors
8.2 Viral Vectors

9 Global Gene Therapy Market – By Indication
9.1 Neurological Diseases
9.2 Hepatological Diseases
9.3 Cancer
9.4 Duchenne Muscular Dystrophy
9.5 Others

10 Global Gene Therapy Market – By Delivery Method
10.1 In Vivo Gene Therapy
10.2 Ex Vivo Gene Therapy

11 Global Gene Therapy Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Gene Therapy Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Gene Therapy Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Biogen
13.3 Gilead Sciences, Inc.
13.4 Anges, Inc.
13.5 Bluebird Bio, Inc.
13.6 Human Stem Cells Institute (HSCI)
13.7 Orchard Therapeutics Plc
13.8 Spark Therapeutics, Inc. (A Part of ýHoffmann-La Roche)
13.9 Amgen, Inc.
13.10 Novartis AG
13.11 Molmed S.P.A.
13.12 Company 11 & more

14 Global Gene Therapy Market – Appendix
14.1 Sources
14.2 Abbreviations